Plaintiffs Add Damages Claims To Bayer Aspirin Suit

Law360, New York (May 8, 2009, 12:00 AM EDT) -- Several plaintiffs have added claims for damages in a proposed class action against Bayer Healthcare LLC over the company’s allegedly illegal marketing of aspirin products as drug dietary supplements that prevent heart and bone disease.

In a first amended complaint filed Thursday in the U.S. District Court for the Eastern District of New York, the plaintiffs, two residents of California, added claims for punitive and compensatory damages.

Their suit against Bayer alleges it markets its Bayer Heart Advantage and Bayer Women’s aspirin products as over-the-counter drug-dietary...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.